| Tomas Pevny, MD | |
|
1450 E Valley Rd, Suite 201, Basalt, CO 81621-8304 | |
| (970) 927-8611 | |
| (970) 927-8633 |
| Full Name | Tomas Pevny |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 34 Years |
| Location | 1450 E Valley Rd, Basalt, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740244342 | NPI | - | NPPES |
| 01345271 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 34527 (Colorado) | Primary |
| 207X00000X | Orthopaedic Surgery | 34527 (Colorado) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Valley View Hospital Association | Glenwood springs, CO | Hospital |
| Aspen Valley Hospital | Aspen, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley View Hospital Association | 1850294778 | 167 |
News Archive
Men with cardiovascular disease are significantly more likely to regret their prostate cancer treatment choice than men without this comorbidity and have an increased risk for adverse effects, US researchers warn.
HLTH Corporation today announced that it has entered into a definitive agreement to sell its Porex segment to affiliates of Aurora Capital Group, a Los Angeles based private equity firm, for $142 million.
immatics biotechnologies GmbH, a biopharmaceutical company developing rationally designed therapeutic vaccines that are active against cancer, announced today that it has completed patient recruitment into the pivotal phase 3 trial evaluating its lead cancer vaccine IMA901 for renal cell carcinoma (RCC). The trial has completed patient inclusion and it is expected that around 345 patients will be randomized across 10 countries in the US and Europe.
McGill researchers have identified a small region in the genome that conclusively plays a role in the development of psychiatric disease and obesity. The key lies in the genomic deletion of brain-derived neurotrophic factor, or BDNF, a nervous system growth factor that plays a critical role in brain development.
Today, the Lupus Research Institute (LRI) released results from the organization's first scientific research impact report entitled, A Decade of Impact in Lupus Research Driving Discovery through Innovation. The results from the report demonstrate a significant impact in lupus research, which has seen no new treatment options approved in 50 years.
› Verified 5 days ago
| Entity Name | Valley View Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730897109 PECOS PAC ID: 1850294778 Enrollment ID: O20040129000027 |
News Archive
Men with cardiovascular disease are significantly more likely to regret their prostate cancer treatment choice than men without this comorbidity and have an increased risk for adverse effects, US researchers warn.
HLTH Corporation today announced that it has entered into a definitive agreement to sell its Porex segment to affiliates of Aurora Capital Group, a Los Angeles based private equity firm, for $142 million.
immatics biotechnologies GmbH, a biopharmaceutical company developing rationally designed therapeutic vaccines that are active against cancer, announced today that it has completed patient recruitment into the pivotal phase 3 trial evaluating its lead cancer vaccine IMA901 for renal cell carcinoma (RCC). The trial has completed patient inclusion and it is expected that around 345 patients will be randomized across 10 countries in the US and Europe.
McGill researchers have identified a small region in the genome that conclusively plays a role in the development of psychiatric disease and obesity. The key lies in the genomic deletion of brain-derived neurotrophic factor, or BDNF, a nervous system growth factor that plays a critical role in brain development.
Today, the Lupus Research Institute (LRI) released results from the organization's first scientific research impact report entitled, A Decade of Impact in Lupus Research Driving Discovery through Innovation. The results from the report demonstrate a significant impact in lupus research, which has seen no new treatment options approved in 50 years.
› Verified 5 days ago
| Entity Name | Aspen Valley Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518960814 PECOS PAC ID: 9234123266 Enrollment ID: O20040413000642 |
News Archive
Men with cardiovascular disease are significantly more likely to regret their prostate cancer treatment choice than men without this comorbidity and have an increased risk for adverse effects, US researchers warn.
HLTH Corporation today announced that it has entered into a definitive agreement to sell its Porex segment to affiliates of Aurora Capital Group, a Los Angeles based private equity firm, for $142 million.
immatics biotechnologies GmbH, a biopharmaceutical company developing rationally designed therapeutic vaccines that are active against cancer, announced today that it has completed patient recruitment into the pivotal phase 3 trial evaluating its lead cancer vaccine IMA901 for renal cell carcinoma (RCC). The trial has completed patient inclusion and it is expected that around 345 patients will be randomized across 10 countries in the US and Europe.
McGill researchers have identified a small region in the genome that conclusively plays a role in the development of psychiatric disease and obesity. The key lies in the genomic deletion of brain-derived neurotrophic factor, or BDNF, a nervous system growth factor that plays a critical role in brain development.
Today, the Lupus Research Institute (LRI) released results from the organization's first scientific research impact report entitled, A Decade of Impact in Lupus Research Driving Discovery through Innovation. The results from the report demonstrate a significant impact in lupus research, which has seen no new treatment options approved in 50 years.
› Verified 5 days ago
| Entity Name | Valley View Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386058188 PECOS PAC ID: 1850294778 Enrollment ID: O20141006002333 |
News Archive
Men with cardiovascular disease are significantly more likely to regret their prostate cancer treatment choice than men without this comorbidity and have an increased risk for adverse effects, US researchers warn.
HLTH Corporation today announced that it has entered into a definitive agreement to sell its Porex segment to affiliates of Aurora Capital Group, a Los Angeles based private equity firm, for $142 million.
immatics biotechnologies GmbH, a biopharmaceutical company developing rationally designed therapeutic vaccines that are active against cancer, announced today that it has completed patient recruitment into the pivotal phase 3 trial evaluating its lead cancer vaccine IMA901 for renal cell carcinoma (RCC). The trial has completed patient inclusion and it is expected that around 345 patients will be randomized across 10 countries in the US and Europe.
McGill researchers have identified a small region in the genome that conclusively plays a role in the development of psychiatric disease and obesity. The key lies in the genomic deletion of brain-derived neurotrophic factor, or BDNF, a nervous system growth factor that plays a critical role in brain development.
Today, the Lupus Research Institute (LRI) released results from the organization's first scientific research impact report entitled, A Decade of Impact in Lupus Research Driving Discovery through Innovation. The results from the report demonstrate a significant impact in lupus research, which has seen no new treatment options approved in 50 years.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tomas Pevny, MD 1450 E Valley Rd, Suite 201, Basalt, CO 81621-8304 Ph: (970) 927-8611 | Tomas Pevny, MD 1450 E Valley Rd, Suite 201, Basalt, CO 81621-8304 Ph: (970) 927-8611 |
News Archive
Men with cardiovascular disease are significantly more likely to regret their prostate cancer treatment choice than men without this comorbidity and have an increased risk for adverse effects, US researchers warn.
HLTH Corporation today announced that it has entered into a definitive agreement to sell its Porex segment to affiliates of Aurora Capital Group, a Los Angeles based private equity firm, for $142 million.
immatics biotechnologies GmbH, a biopharmaceutical company developing rationally designed therapeutic vaccines that are active against cancer, announced today that it has completed patient recruitment into the pivotal phase 3 trial evaluating its lead cancer vaccine IMA901 for renal cell carcinoma (RCC). The trial has completed patient inclusion and it is expected that around 345 patients will be randomized across 10 countries in the US and Europe.
McGill researchers have identified a small region in the genome that conclusively plays a role in the development of psychiatric disease and obesity. The key lies in the genomic deletion of brain-derived neurotrophic factor, or BDNF, a nervous system growth factor that plays a critical role in brain development.
Today, the Lupus Research Institute (LRI) released results from the organization's first scientific research impact report entitled, A Decade of Impact in Lupus Research Driving Discovery through Innovation. The results from the report demonstrate a significant impact in lupus research, which has seen no new treatment options approved in 50 years.
› Verified 5 days ago
Ferdinand Jesus Liotta, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1450 E Valley Rd, Suite 201, Basalt, CO 81621 Phone: 970-927-8611 Fax: 970-927-8633 | |
Thomas P Moore, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Elk Run Dr Ste 229, Basalt, CO 81621 Phone: 970-927-3344 Fax: 970-927-9555 | |
Dr. Stanley Gertzbein, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 670 Frying Pan Rd, Basalt, CO 81621 Phone: 713-269-2266 |